Skip to search.
 FTSE 100 Up 0.24%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
480.09 Up 0.01(0.00%) 24 Apr 21:00
|After Hours: : 480.50 Up 0.41 (0.09%) 24 Apr 23:25
Add to Portfolio
Prev Close:480.08
Open:478.91
Bid:475.20 x 200
Ask:486.44 x 500
1y Target Est:455.30
Beta:0.58
Next Earnings Date: 7-May-15REGN Earnings announcement
Day's Range:475.02 - 486.00
52wk Range:269.50 - 495.50
Volume:909,087
Avg Vol (3m):843,830
Market Cap:49.58b
P/E (ttm):156.38
EPS (ttm):3.07
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNUp 0.00%49.58b
AMGNDown 0.74%127.61b
NVSDown 1.16%250.13b
RHHBYDown 0.83%N/A

Key Statistics

Forward P/E (1 yr):38.01
P/S (ttm):17.35
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :10.80
Quarterly EPS Est (Mar-15) :2.70
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.36

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback